portion

Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα…

4 days ago
Byrna Donating a Portion of Online Sales to Support Recovery Efforts for Los Angeles Wildfire VictimsByrna Donating a Portion of Online Sales to Support Recovery Efforts for Los Angeles Wildfire Victims

Byrna Donating a Portion of Online Sales to Support Recovery Efforts for Los Angeles Wildfire Victims

January 15, 2025 16:05 ET  | Source: Byrna Technologies, Inc. ANDOVER, Mass., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies…

2 months ago